Self intra-cavernous injections as a successful treatment in pure neurogenic impotence.
Riv Neurol
; 61(1): 35-8, 1991.
Article
en En
| MEDLINE
| ID: mdl-1857921
The aim of our research is to investigate the success of the vasoactive intracavernous therapy in subjects suffering impotence only on a neurological basis. We have submitted 50 subjects to a multisciplinary study including P.B.P.I., intracavernous minitest plus V.S.S., M.M.P.I., B.C.R. latency, duration, aspect and an hormonal screening (SH, LH, PRL, F. TEST, 17 BE2). The patients, or their partners, were instructed in the technique of self intracavernous injection (S.I.C.I.) of vasoactive drugs. Papaverine alone was given to 37 patients in a mean dose of 20.8 +/- 11.7 mg. Other 13 patients were treated with papaverine plus phentolamine in order to obtain a full erection. Comprehensive results of the treatment were judged at 80% effective: only 10 patients discontinued self injection treatment, unable to perform this technique properly.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Disfunción Eréctil
Límite:
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Riv Neurol
Año:
1991
Tipo del documento:
Article
Pais de publicación:
Italia